11498 related articles for article (PubMed ID: 14691188)
1. Contrast-processing deficits in melanoma-associated retinopathy.
Alexander KR; Barnes CS; Fishman GA; Pokorny J; Smith VC
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):305-10. PubMed ID: 14691188
[TBL] [Abstract][Full Text] [Related]
2. Contrast sensitivity deficits in inferred magnocellular and parvocellular pathways in retinitis pigmentosa.
Alexander KR; Barnes CS; Fishman GA; Pokorny J; Smith VC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4510-9. PubMed ID: 15557462
[TBL] [Abstract][Full Text] [Related]
3. Anisometropic amblyopia: spatial contrast sensitivity deficits in inferred magnocellular and parvocellular vision.
Zele AJ; Pokorny J; Lee DY; Ireland D
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3622-31. PubMed ID: 17652732
[TBL] [Abstract][Full Text] [Related]
4. Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy.
Alexander KR; Barnes CS; Fishman GA; Milam AH
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1189-97. PubMed ID: 11923265
[TBL] [Abstract][Full Text] [Related]
5. Deficits in temporal integration for contrast processing in retinitis pigmentosa.
Alexander KR; Barnes CS; Fishman GA
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3163-9. PubMed ID: 12824267
[TBL] [Abstract][Full Text] [Related]
6. Contrast discrimination deficits in retinitis pigmentosa are greater for stimuli that favor the magnocellular pathway.
Alexander KR; Pokorny J; Smith VC; Fishman GA; Barnes CS
Vision Res; 2001 Mar; 41(5):671-83. PubMed ID: 11226510
[TBL] [Abstract][Full Text] [Related]
7. Spatial frequencies used in Landolt C orientation judgments: relation to inferred magnocellular and parvocellular pathways.
McAnany JJ; Alexander KR
Vision Res; 2008 Nov; 48(26):2615-24. PubMed ID: 18374385
[TBL] [Abstract][Full Text] [Related]
8. Luminance noise as a novel approach for measuring contrast sensitivity within the magnocellular and parvocellular pathways.
Hall CM; McAnany JJ
J Vis; 2017 Jul; 17(8):5. PubMed ID: 28672370
[TBL] [Abstract][Full Text] [Related]
9. Functional loss in the magnocellular and parvocellular pathways in patients with optic neuritis.
Cao D; Zele AJ; Pokorny J; Lee DY; Messner LV; Diehl C; Ksiazek S
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8900-7. PubMed ID: 22016061
[TBL] [Abstract][Full Text] [Related]
10. Contrast sensitivity for letter optotypes vs. gratings under conditions biased toward parvocellular and magnocellular pathways.
McAnany JJ; Alexander KR
Vision Res; 2006 May; 46(10):1574-84. PubMed ID: 16213001
[TBL] [Abstract][Full Text] [Related]
11. Low spatial frequency contrast sensitivity deficits in migraine are not visual pathway selective.
McKendrick AM; Sampson GP
Cephalalgia; 2009 May; 29(5):539-49. PubMed ID: 19250285
[TBL] [Abstract][Full Text] [Related]
12. Spatial frequency processing in inferred PC- and MC-pathways.
Leonova A; Pokorny J; Smith VC
Vision Res; 2003 Sep; 43(20):2133-9. PubMed ID: 12855249
[TBL] [Abstract][Full Text] [Related]
13. Contrast sensitivity changes due to glaucoma and normal aging: low-spatial-frequency losses in both magnocellular and parvocellular pathways.
McKendrick AM; Sampson GP; Walland MJ; Badcock DR
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2115-22. PubMed ID: 17460269
[TBL] [Abstract][Full Text] [Related]
14. Selective magnocellular damage in melanoma-associated retinopathy: comparison with congenital stationary nightblindness.
Wolf JE; Arden GB
Vision Res; 1996 Aug; 36(15):2369-79. PubMed ID: 8776501
[TBL] [Abstract][Full Text] [Related]
15. Selective broad-band spatial frequency loss in contrast sensitivity functions. Comparison with a model based on optical transfer functions.
Bour LJ; Apkarian P
Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2475-84. PubMed ID: 8933764
[TBL] [Abstract][Full Text] [Related]
16. Contrast-processing dysfunction in both magnocellular and parvocellular pathways in migraineurs with or without aura.
McKendrick AM; Badcock DR
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):442-8. PubMed ID: 12506107
[TBL] [Abstract][Full Text] [Related]
17. Contrast sensitivity mediated by inferred magno- and parvocellular pathways in type 2 diabetics with and without nonproliferative retinopathy.
Gualtieri M; Bandeira M; Hamer RD; Damico FM; Moura AL; Ventura DF
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1151-5. PubMed ID: 21051718
[TBL] [Abstract][Full Text] [Related]
18. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.
Lei B; Bush RA; Milam AH; Sieving PA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):262-6. PubMed ID: 10634629
[TBL] [Abstract][Full Text] [Related]
19. Flicker adaptation desensitizes the magnocellular but not the parvocellular pathway.
Zhuang X; Pokorny J; Cao D
Invest Ophthalmol Vis Sci; 2015 May; 56(5):2901-8. PubMed ID: 26029886
[TBL] [Abstract][Full Text] [Related]
20. Determinants of contrast sensitivity for the tumbling E and Landolt C.
Alexander KR; McAnany JJ
Optom Vis Sci; 2010 Jan; 87(1):28-36. PubMed ID: 19996815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
